Valuation: Roopa Industries Limited

Market Cap 354M 3.69M 3.24M 3.05M 2.79M 5.22M 5.26M 36.57M 14.2M 180M 13.85M 13.55M 586M P/E 2025
19.8x
P/E 2026 371x
Enterprise Value 664M 6.92M 6.08M 5.72M 5.23M 9.78M 9.86M 68.56M 26.62M 338M 25.97M 25.4M 1.1B EV / Sales 2025
0.58x
EV / Sales 2026 0.48x
Free-Float
36.13%
Yield 2025 *
-
Yield 2026 -
1 day+0.18%
1 week+4.41%
Current month-6.25%
1 month-3.12%
3 months-6.85%
6 months+0.20%
Current year+2.18%
1 week 40.71
Extreme 40.71
46.85
1 month 40.71
Extreme 40.71
53.9
Current year 38.1
Extreme 38.1
63.4
1 year 38.1
Extreme 38.1
63.4
3 years 38.1
Extreme 38.1
114.9
5 years 15.3
Extreme 15.3
114.9
10 years 6.82
Extreme 6.82
114.9
Manager TitleAgeSince
Chief Executive Officer 72 1997-12-31
Director of Finance/CFO - 2020-06-30
Compliance Officer - 2022-05-31
Director TitleAgeSince
Chairman 72 1997-12-31
Director/Board Member 70 1997-03-16
Director/Board Member 54 2017-08-25
Change 5-day change 1-year change 3-year change Capi.($)
+0.18%+4.41%-21.05%+1.15% 3.69M
+2.68%+3.87%+58.22%+114.68% 1,026B
+0.56%+1.27%+53.29%+68.65% 649B
+0.02%+0.99%+19.10%+73.58% 468B
+0.06%+0.25%+37.03%+45.71% 352B
+1.16%+4.10%+21.99%+29.39% 271B
-0.24%+2.18%+10.14%+12.26% 256B
-0.01%+7.89%+41.57%+51.68% 220B
-1.11%+1.36%+30.85%+99.56% 188B
+0.30%-7.19%-32.43%-60.56% 170B
Average +0.09%+1.55%+21.87%+43.61% 359.91B
Weighted average by Cap. +0.16%+1.26%+37.30%+67.68%

Financials

2025 2026
Net sales 1.21B 12.63M 11.1M 10.45M 9.56M 17.86M 18.01M 125M 48.61M 617M 47.42M 46.38M 2.01B 1.28B 13.3M 11.68M 11M 10.06M 18.8M 18.97M 132M 51.18M 650M 49.93M 48.84M 2.11B
Net income 20.35M 212K 186K 175K 161K 300K 303K 2.1M 816K 10.37M 796K 779K 33.69M 831K 8.66K 7.61K 7.17K 6.55K 12.25K 12.35K 85.86K 33.34K 423K 32.52K 31.81K 1.38M
Net Debt 299M 3.11M 2.74M 2.58M 2.36M 4.4M 4.44M 30.88M 11.99M 152M 11.7M 11.44M 495M 310M 3.23M 2.84M 2.67M 2.44M 4.56M 4.6M 31.99M 12.42M 158M 12.11M 11.85M 513M
Logo Roopa Industries Limited
Roopa Industries Limited is an India-based active pharma ingredient (API) and pharmaceutical intermediates manufacturing company. The Company is focused on its core business Triphenyl Phosphine (TPP) and its allied products. Its products include N,N- Dicyclohexylcarbodiimide (DCC); TPP; 5-Cyano Phthalide, and bromine and its derivatives. TPP is a product used by the manufacturers of Cephalosporin group of Antibiotics, Statins and others. TTP are more used in areas like specialty resins/paints, fire retardants, Phosphonium salts, phase transfer catalysts, products relating to agriculture and others. Glucosamine is a sheet anchor product of the Company, which is a nutraceutical/nutritional supplement. It has capabilities to deliver bromine and bromine compounds of any quantity and specifications, such as Meta Bromo Anisole, Tetra Butyl Ammonium Bromide, 1-Bromo-3-Chloropropane, 1-Acetoxy Ethyl Bromide and others, which are used in chemical and pharmaceutical industry.
Employees
56
Date Price Change Volume
26-09-24 ₹45.00 +0.18% 401
26-09-23 ₹44.92 +4.08% 3,167
26-09-22 ₹43.16 +0.51% 1,162
26-09-21 ₹42.94 -2.65% 3,134
26-09-18 ₹44.11 +0.27% 122
  1. Stock Market
  2. Stocks
  3. ROOPAIND6 Stock